CIK 0001549595 · Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270838048
- Phone
- (415) 660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,712,859
- in 10 filings, $1.0M under 10b5-1 plans
Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-26 | van Houte Hans Chief Financial Officer | Sale 10b5-1 | −20,000 | $25.22 | $504K | 31,002 |
| 2024-08-01 | van Houte Hans Chief Financial Officer | Sale 10b5-1 | −3,377 | $21.43 | $72K | 51,102 |
| 2024-08-01 | van Houte Hans Chief Financial Officer | Sale 10b5-1 | −100 | $22.22 | $2K | 51,002 |
| 2024-08-01 | Ring Christine Chief Legal Officer | Option exercise 10b5-1 | +5,760 | $1.86 | $11K | 30,352 |
| 2024-08-01 | Ring Christine Chief Legal Officer | Sale 10b5-1 | −5,460 | $21.39 | $117K | 24,892 |
| 2024-08-01 | Ring Christine Chief Legal Officer | Sale 10b5-1 | −300 | $22.18 | $7K | 24,592 |
| 2024-08-01 | Ring Christine Chief Legal Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,760 | 82,786 | ||
| 2024-07-30 | Hansen Gwenn Chief Scientific Officer | Option exercise | +3,207 | 42,808 | ||
| 2024-07-30 | Hansen Gwenn Chief Scientific Officer | Option exercise | +2,000 | 44,808 | ||
| 2024-07-30 | Hansen Gwenn Chief Scientific Officer | Option exercise | +3,750 | 48,558 | ||
| 2024-07-30 | Hansen Gwenn Chief Scientific Officer | Sale | −3,408 | $20.67 | $70K | 45,150 |
| 2024-07-30 | Hansen Gwenn Chief Scientific Officer | Option exercise · Restricted Stock Units | −3,207 | 19,241 | ||
| 2024-07-30 | Hansen Gwenn Chief Scientific Officer | Option exercise · Restricted Stock Units | −2,000 | 14,000 | ||
| 2024-07-30 | Hansen Gwenn Chief Scientific Officer | Option exercise · Restricted Stock Units | −3,750 | 41,250 | ||
| 2024-07-30 | Ring Christine Chief Legal Officer | Option exercise | +1,924 | 21,762 | ||
| 2024-07-30 | Ring Christine Chief Legal Officer | Option exercise | +2,000 | 23,762 | ||
| 2024-07-30 | Ring Christine Chief Legal Officer | Option exercise | +3,750 | 27,512 | ||
| 2024-07-30 | Ring Christine Chief Legal Officer | Sale | −2,920 | $20.67 | $60K | 24,592 |
| 2024-07-30 | Ring Christine Chief Legal Officer | Option exercise · Restricted Stock Units | −1,924 | 11,545 | ||
| 2024-07-30 | Ring Christine Chief Legal Officer | Option exercise · Restricted Stock Units | −2,000 | 14,000 |
Page 19 of 20 · 381 trades